[EN] HCV PROTEASE INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉASES DE VHC
申请人:TAIGEN BIOTECHNOLOGY CO LTD
公开号:WO2011034518A1
公开(公告)日:2011-03-24
This invention relates to macrocyclic compounds shown in the specification. These compounds can be used to treat hepatitis C virus infection.
这项发明涉及说明书中显示的大环化合物。这些化合物可用于治疗丙型肝炎病毒感染。
HCV PROTEASE INHIBITORS
申请人:Taigen Biotechnology Co., Ltd.
公开号:EP2274281B1
公开(公告)日:2015-05-27
[EN] HCV PROTEASE INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉASE DU VHC
申请人:TAIGEN BIOTECHNOLOGY CO LTD
公开号:WO2009139792A1
公开(公告)日:2009-11-19
This invention relates to macrocyclic compounds of formula (I) or (II) shown in the specification. These compounds can be used to treat hepatitis C virus infection.
Yamaguchi, Seiji; Tsuzuki, Kunihiro; Sannomiya, Yoshie, Journal of Heterocyclic Chemistry, 1989, vol. 26, p. 285 - 287